List view / Grid view

MGC Pharmaceuticals

 

article

A novel cannabinoid formulation for glioblastoma treatment

25 August 2020 | By

Earlier this year, MGC Pharmaceuticals, in collaboration with the Slovenian National Institute of Biology (NIB) and the Neurosurgery Department at the University Medical Centre in Ljubljana, Slovenia, announced successful research results for their novel cannabinoid formulation, which has been developed for the treatment of glioblastoma. This article highlights the key…